Shiyun Tang

Department of Urology, hospital of chengdu university of traditional chinese medicine

Affiliated withhospital of chengdu university of traditional chinese medicine

Research Area

Biography

Shiyun Tang has not added Biography.
If you are Shiyun Tang and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 2	2025
Publication title	2025

Other Publications

Article	Year
Rab-like protein 1 A is upregulated by cisplatin treatment and partially inhibits chemoresistance by regulating p53 activity. Oncology letters\| PubMed ID: 30197676	2018
[Large- scale prospective clinical study on prophylactic intervention of COVID-19 in community population using Huoxiang Zhengqi Oral Liquid and Jinhao Jiere Granules]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica\| PubMed ID: 32726003	2020
A randomized controlled clinical trial study protocol of Liuwei Dihuang pills in the adjuvant treatment of diabetic kidney disease. Medicine\| PubMed ID: 32756091	2020
Effects and safety of herbal medicines among community-dwelling residents during COVID-19 pandemic: A large prospective, randomized controlled trial (RCT). Phytomedicine : international journal of phytotherapy and phytopharmacology\| PubMed ID: 33419674	2021
The science behind TCM and Gut microbiota interaction-their combinatorial approach holds promising therapeutic applications. Frontiers in cellular and infection microbiology\| PubMed ID: 36176581	2022
Bujing Yishi tablets alleviate photoreceptor cells death via the P2X7R/CX3CL1/CX3CR1 pathway in Retinitis Pigmentosa rats. Phytomedicine : international journal of phytotherapy and phytopharmacology\| PubMed ID: 37116386	2023
Translation Animal Models of Diabetic Kidney Disease: Biochemical and Histological Phenotypes, Advantages and Limitations. Diabetes, metabolic syndrome and obesity : targets and therapy\| PubMed ID: 37179788	2023
Radical oxygen species: an important breakthrough point for botanical drugs to regulate oxidative stress and treat the disorder of glycolipid metabolism. Frontiers in pharmacology\| PubMed ID: 37251336	2023
Chelerythrine chloride inhibits the progression of colorectal cancer by targeting cancer-associated fibroblasts through intervention with WNT10B/β-catenin and TGFβ2/Smad2/3 axis. Phytotherapy research : PTR\| PubMed ID: 37402476	2023
Targeting extracellular matrix through phytochemicals: a promising approach of multi-step actions on the treatment and prevention of cancer. Frontiers in pharmacology\| PubMed ID: 37560476	2023
Purine and purinergic receptors in health and disease. MedComm\| PubMed ID: 37692109	2023
Tanshinone I attenuates gastric precancerous lesions by inhibiting epithelial mesenchymal transition through the p38/STAT3 pathway. International immunopharmacology\| PubMed ID: 37699302	2023
Jin-Gui-Shen-Qi Wan ameliorates diabetic retinopathy by inhibiting apoptosis of retinal ganglion cells through the Akt/HIF-1α pathway. Chinese medicine\| PubMed ID: 37828620	2023
Corrigendum: The science behind TCM and Gut microbiota interaction-their combinatorial approach holds promising therapeutic applications. Frontiers in cellular and infection microbiology\| PubMed ID: 37900314	2023
Natural products in traditional Chinese medicine: molecular mechanisms and therapeutic targets of renal fibrosis and state-of-the-art drug delivery systems. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie\| PubMed ID: 38157643	2024
Jin-Gui-Shen-Qi Wan alleviates fibrosis in mouse diabetic nephropathy via MHC class II. Journal of ethnopharmacology\| PubMed ID: 38228231	2024
Network pharmacology combined with Mendelian randomization analysis to identify the key targets of renin-angiotensin-aldosterone system inhibitors in the treatment of diabetic nephropathy. Frontiers in endocrinology\| PubMed ID: 38332893	2024
Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk. Frontiers in immunology\| PubMed ID: 38481995	2024
An exploration of the causal relationship between 731 immunophenotypes and osteoporosis: a bidirectional Mendelian randomized study. Frontiers in endocrinology\| PubMed ID: 39086903	2024
Natural products derived from traditional Chinese medicines targeting ER stress for the treatment of kidney diseases. Renal failure\| PubMed ID: 39192602	2024
Mendelian randomization analysis reveals causal factors behind diabetic nephropathy: evidence, opportunities, and challenges. Frontiers in endocrinology\| PubMed ID: 39735650	2024
The efficacy and safety of L. leaves extract combined with ACEI/ARB on diabetic kidney disease: a systematic review and meta-analysis of 41 randomized controlled trials. Frontiers in pharmacology\| PubMed ID: 39830333	2024
Shenqi compound ameliorates renal fibrosis in diabetic kidney disease by inhibiting LRG1/TGF-β/Smad signaling pathway. Phytomedicine : international journal of phytotherapy and phytopharmacology\| PubMed ID: 41075516	2025